Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rab9 effector protein with kelch motifs (RABEPK) is a monomeric cytosolic and membrane-associated protein characterized by six kelch repeats which form a β-propeller structure that mediates protein-protein interactions[1][3]. RABEPK binds to the active, GTP-bound form of Rab9 GTPase with high specificity and facilitates the transport and docking of vesicles carrying mannose 6-phosphate receptors from endosomes to the trans-Golgi network, a process essential for proper lysosomal enzyme trafficking and cellular logistics[1][2][4][5][6][8]. This protein does not interact with closely related Rabs such as Rab7, and appears to inhibit the GTPase activity of Rab9[1]. While crucial for intracellular membrane trafficking, RABEPK is not currently considered a direct pharmacological target, nor does it have established roles as a biomarker or safety concern in clinical settings[5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rab9 effector protein with kelch motifs (RABEPK).